The results of our present study indicate that genetic variants of TNFSF13 and TNFRSF13B genes may be considered as potential risk factors of CLL and that these variants may have an impact on APRIL and TACI molecules expression. This evidence concerns the gene TNFRSF13B and B-cell chronic lymphocytic leukemia.